Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML

Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML - Cohort study for the prognosis of high risk MDS and MDS/secondary AML

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-C000000399

Enrollment

250

Registered

2006-04-17

Start date

2006-04-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High risk myelodysplastic syndrome and MDS/secondary AML

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with high risk MDS and MDS/secondary AML Age above 15 years old

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Efficacy of allo-stem cell transplantation in the survival of high risk MDS and MDS/secondary AML	—

Countries

Japan

Contacts

Public ContactMitsuhiro Matsuda, MD, PhD

JALSG MDS206 study office Department of Hematology, Kinki University School of Medicine

mmatsuda@med.kindai.ac.jp072-366-0221

Outcome results